Structure Therapeutics Change in Inventories 2022-2025 | GPCR

Structure Therapeutics change in inventories from 2022 to 2025. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.

Structure Therapeutics Change in Inventories 2022-2025 | GPCR

Structure Therapeutics change in inventories from 2022 to 2025. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$231.3B
Amgen (AMGN)$162.4B
Gilead Sciences (GILD)$142.4B
Vertex Pharmaceuticals (VRTX)$121.3B
Bristol Myers Squibb (BMY)$92.4B
CSL (CSLLY)$84B
GSK (GSK)$76.9B
Regeneron Pharmaceuticals (REGN)$61.7B
Alnylam Pharmaceuticals (ALNY)$55B
Argenex SE (ARGX)$42.2B
BioNTech SE (BNTX)$26.5B
Royalty Pharma (RPRX)$21.3B
Insmed (INSM)$21.1B
Biogen (BIIB)$19.4B
Incyte (INCY)$15.2B
Illumina (ILMN)$15.1B
Genmab (GNMSF)$14.7B
Genmab (GMAB)$14.1B
BioMarin Pharmaceutical (BMRN)$11.6B
Ascendis Pharma (ASND)$11.3B
QIAGEN (QGEN)$11.2B
Moderna (MRNA)$10.8B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Exelixis (EXEL)$9.9B
Verona Pharma American Depositary Share (VRNA)$9B
Exact Sciences (EXAS)$8.8B
Bio-Techne Corp (TECH)$8.6B
Blueprint Medicines (BPMC)$8.3B
Roivant Sciences (ROIV)$7.8B
Halozyme Therapeutics (HALO)$7.4B